At a recent medical conference, a concept came up that’s worth unpacking for anyone navigating ANCA-associated vasculitis: minimal symptom expression, or MSE. It was presented as a way clinicians assess whether a disease is controlled or in remission. On the surface, it sounds promising — who wouldn’t want…
Certain T-cells may show excessive activity in a signaling pathway called STAT3-PIM1 in people with granulomatosis with polyangiitis (GPA) who test positive for antibodies against proteinase 3 (PR3-GPA), according to a new study. Researchers aimed to identify unique activity patterns in T-cells containing the CD4 protein marker (CD4+ T-cells),…
Discussion
Note: This column describes the author’s own experiences with, or observations of, several medications. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. I have eosinophilic granulomatosis with polyangiitis (EGPA), a type of ANCA-associated vasculitis (AAV) that is not indicated…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
